LOS ANGELES, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- SpineX, Inc., an early stage medtech company today announced FDA Breakthrough Device Designation for SCiP (Spinal Cord Innovation in Pediatrics) ...
LOS ANGELES--(BUSINESS WIRE)--SpineX Inc., a clinical stage bioelectric medtech company, is pleased to announce receipt of funding from the National Institutes of Health (NIH) through the Small ...
LOS ANGELES--(BUSINESS WIRE)--SpineX Inc. today announced groundbreaking results in its first in-human study treating an adult with Cerebral Palsy (CP). The study, published in the esteemed medical ...
Non-invasive therapy: The set-up of the SCiP device, demonstrating the placement of the non-invasive electrodes over the cervical and thoracic regions of the spinal cord. (Courtesy: CC BY 4.0/Nat.
SpineX publishes results from first in human study using its proprietary non-surgical and non- invasive device SCiP to treat children with cerebral palsy ...
SCiP: Non-surgical and non invasive treatment for Cerebral Palsy. A CP mom shares her son's experience after SCiP therapy. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback